These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8251377)

  • 1. Genotyping provides a reliable tool for the determination of the platelet antigen system HPA-1 in Glanzmann's thrombasthenia.
    Pober M; Kyrle PA; Panzer S
    Br J Haematol; 1993 Sep; 85(1):112-5. PubMed ID: 8251377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet alloantigen polymorphism in Glanzmann's thrombasthenia and its impact on the severity of the disease.
    Ghosh K; Kulkarni B; Nair S; Shetty S; Mohanty D
    Br J Haematol; 2002 Nov; 119(2):348-53. PubMed ID: 12406067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defect.
    Morel-Kopp MC; Clemenceau S; Schlegel N; Lecompte T; Aurousseau MH; Kaplan C
    Transfus Med; 1995 Jun; 5(2):123-9. PubMed ID: 7655575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological study of platelet glycoproteins and alloantigens in families of patients with Glanzmann's thrombasthenia.
    Boizard-Boval B; Wautier JL; Gruel Y; Caen JP
    Nouv Rev Fr Hematol (1978); 1992; 34(1):93-8. PubMed ID: 1523103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral linkage between a new deletion polymorphism in intron 21 of the GP IIb gene and the HPA-3b (Bakb) determinant.
    Peyruchaud O; Nurden A; Bourre F
    Br J Haematol; 1995 Nov; 91(3):747-51. PubMed ID: 8555087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet alloantigen typing: PCR analysis is not a substitute for serological methods.
    Morel-Kopp MC; Clemenceau S; Aurousseau MH; Schlegel N; Kaplan C
    Transfus Med; 1994 Mar; 4(1):9-14. PubMed ID: 7912136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal-neonatal alloimmune thrombocytopenia and unexpected Glanzmann thrombasthenia carrier: report of two cases.
    Jallu V; Bianchi F; Kaplan C
    Transfusion; 2005 Apr; 45(4):550-3. PubMed ID: 15819676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.
    Lanza F; Stierlé A; Fournier D; Morales M; André G; Nurden AT; Cazenave JP
    J Clin Invest; 1992 Jun; 89(6):1995-2004. PubMed ID: 1602006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
    Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
    Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia.
    Burk CD; Newman PJ; Lyman S; Gill J; Coller BS; Poncz M
    J Clin Invest; 1991 Jan; 87(1):270-6. PubMed ID: 1702098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glanzmann's thrombasthenia: updated.
    Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
    Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA.
    Simsek S; Heyboer H; de Bruijne-Admiraal LG; Goldschmeding R; Cuijpers HT; von dem Borne AE
    Blood; 1993 Apr; 81(8):2044-9. PubMed ID: 8471765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel homozygous mutation (c.175delG) in platelet glycoprotein ITGA2B gene as cause of Glanzmann's thrombasthenia type I.
    Vannier C; Behnisch W; Bartsch I; Sandrock K; Ertle F; Schmidt K; Busse A; Superti-Furga A; Kulozik A; Santoso S; Zieger B
    Klin Padiatr; 2010 May; 222(3):150-3. PubMed ID: 20514618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex.
    Kato A; Yamamoto K; Miyazaki S; Jung SM; Moroi M; Aoki N
    Blood; 1992 Jun; 79(12):3212-8. PubMed ID: 1317725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
    Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
    Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
    Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
    Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies.
    Kashyap R; Kriplani A; Saxena R; Takkar D; Choudhry VP
    J Obstet Gynaecol Res; 1997 Jun; 23(3):247-50. PubMed ID: 9255036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two human antibodies reacting with different epitopes on integrin beta 3 of platelets and endothelial cells.
    Jallu V; Diaz-Ricart M; Ordinas A; Pico M; Vezon G; Nurden AT
    Eur J Biochem; 1994 Jun; 222(3):743-51. PubMed ID: 7517865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia.
    Giltay JC; Brinkman HJ; von dem Borne AE; van Mourik JA
    Blood; 1989 Aug; 74(3):965-70. PubMed ID: 2473812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.